Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

ZUP1 inhibits Middle East Respiratory Syndrome Coronavirus. 1 / 1

| 1

➶

reach

"Importantly, selective interference of PLpro DUB activity could enable future engineering of replication-competent, DUB-deficient MERS-CoV that could be used to investigate the role of PLpro DUB activity during MERS-CoV infection.Not surprisingly, MERS-CoV PLpro has been identified as a target for small-molecule drug design [159], [165], [166], but the development of MERS-CoV-specific antiviral compounds remains in its early stages."

28625850

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...